Combination chemotherapy with 5-fluorouracil and dacarbazine in advanced medullary thyroid cancer, a possible alternative?

Authors

  • Lucien Marchand Department of Endocrinology, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron, France
  • Cécile Nozières Department of Endocrinology, Centre Hospitalier de Vienne, Vienne, France
  • Thomas Walter Department of Oncology, Hospices Civils de Lyon, Hôpital Edouard Herriot, Lyon, France; Lyon 1 University, CRCL INSERM U1052
  • Françoise Descotes Department of Biochemistry, Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Pierre Bénite, France
  • Myriam Decaussin-Petrucci Department of Pathology, Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Pierre Bénite, France
  • Marie-Odile Joly Department of Central Anatomy and Pathological Cytology, Hospices Civils de Lyon, Hôpital Edouard Herriot, Lyon, France; Lyon 1 University, CRCL INSERM U1052
  • Véronique Lapras Department of Radiology, Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Pierre Bénite, France
  • Claire Bournaud Department of Nuclear Medicine, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron, France
  • Françoise Borson-Chazot Department of Endocrinology, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron, France; Lyon 1 University, CRCL INSERM U1052

DOI:

https://doi.org/10.3109/0284186X.2016.1157264

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Additional Files

Published

2016-08-02

How to Cite

Marchand, L., Nozières, C., Walter, T., Descotes, F., Decaussin-Petrucci, M., Joly, M.-O., … Borson-Chazot, F. (2016). Combination chemotherapy with 5-fluorouracil and dacarbazine in advanced medullary thyroid cancer, a possible alternative?. Acta Oncologica, 55(8), 1064–1066. https://doi.org/10.3109/0284186X.2016.1157264

Issue

Vol. 55 No. 8 (2016): Acta Oncologica

Section

Articles